A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study

Maria Donata Benedetti, Maura Pugliatti, Roberto Dalessandro, Ettore Beghi, Adriano Chiò, Giancarlo Logroscino, Graziella Filippini, Francesca Galeotti, Marco Massari, Carmela Santuccio, Roberto Raschetti

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To assess Guillain-Barre syndrome (GBS) incidence we relied on the Italian Network for the study of GBS (ITANG) established in 2010 in 7 Italian regions to analyse the association between influenza vaccination and GBS. Methods: All individuals aged ≥18 years, presenting with clinical manifestations that suggested GBS according to the universally accepted Asbury's diagnostic criteria (1990) were prospectively notified to a centralised database by ITANG neurologists over the period October 1, 2010-September 30, 2011. Through a telephone survey, 9 trained interviewers followed up the cases to diagnosis and then for 1 year since hospital discharge. Validation of case reporting was performed with the support of administrative data in 5 regions. Results: We found 365 cases fulfilling the definition for GBS or one of its variants over 19,846,068 population ≥18 years of age, yielding an annual incidence rate of 1.84 per 100,000 (95% CI 1.65-2.03), 2.30 (95% CI 1.99-2.60) in men and 1.41 (95% CI 1.18-1.64) in women. A highly significant peak of incidence was observed in February 2011 as compared to reference month (September 2011, rate ratio 3.3:1, p <0.01). Conclusions: In Italy, GBS incidence was among the highest reported in Europe and higher than previously observed in Italian studies.

Original languageEnglish
Pages (from-to)90-99
Number of pages10
JournalNeuroepidemiology
Volume45
Issue number2
DOIs
Publication statusPublished - Oct 12 2015

Fingerprint

Guillain-Barre Syndrome
Italy
Cohort Studies
Prospective Studies
Incidence
Telephone
Human Influenza
Vaccination
Databases
Interviews
Population

Keywords

  • Axonal and demyelinating GBS
  • Guillain-Barré syndrome
  • Incidence
  • Prospective study
  • Trend

ASJC Scopus subject areas

  • Epidemiology
  • Clinical Neurology

Cite this

Benedetti, M. D., Pugliatti, M., Dalessandro, R., Beghi, E., Chiò, A., Logroscino, G., ... Raschetti, R. (2015). A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study. Neuroepidemiology, 45(2), 90-99. https://doi.org/10.1159/000438752

A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study. / Benedetti, Maria Donata; Pugliatti, Maura; Dalessandro, Roberto; Beghi, Ettore; Chiò, Adriano; Logroscino, Giancarlo; Filippini, Graziella; Galeotti, Francesca; Massari, Marco; Santuccio, Carmela; Raschetti, Roberto.

In: Neuroepidemiology, Vol. 45, No. 2, 12.10.2015, p. 90-99.

Research output: Contribution to journalArticle

Benedetti, MD, Pugliatti, M, Dalessandro, R, Beghi, E, Chiò, A, Logroscino, G, Filippini, G, Galeotti, F, Massari, M, Santuccio, C & Raschetti, R 2015, 'A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study', Neuroepidemiology, vol. 45, no. 2, pp. 90-99. https://doi.org/10.1159/000438752
Benedetti, Maria Donata ; Pugliatti, Maura ; Dalessandro, Roberto ; Beghi, Ettore ; Chiò, Adriano ; Logroscino, Giancarlo ; Filippini, Graziella ; Galeotti, Francesca ; Massari, Marco ; Santuccio, Carmela ; Raschetti, Roberto. / A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study. In: Neuroepidemiology. 2015 ; Vol. 45, No. 2. pp. 90-99.
@article{275b9abc57294eb4ae042f9a25157566,
title = "A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study",
abstract = "To assess Guillain-Barre syndrome (GBS) incidence we relied on the Italian Network for the study of GBS (ITANG) established in 2010 in 7 Italian regions to analyse the association between influenza vaccination and GBS. Methods: All individuals aged ≥18 years, presenting with clinical manifestations that suggested GBS according to the universally accepted Asbury's diagnostic criteria (1990) were prospectively notified to a centralised database by ITANG neurologists over the period October 1, 2010-September 30, 2011. Through a telephone survey, 9 trained interviewers followed up the cases to diagnosis and then for 1 year since hospital discharge. Validation of case reporting was performed with the support of administrative data in 5 regions. Results: We found 365 cases fulfilling the definition for GBS or one of its variants over 19,846,068 population ≥18 years of age, yielding an annual incidence rate of 1.84 per 100,000 (95{\%} CI 1.65-2.03), 2.30 (95{\%} CI 1.99-2.60) in men and 1.41 (95{\%} CI 1.18-1.64) in women. A highly significant peak of incidence was observed in February 2011 as compared to reference month (September 2011, rate ratio 3.3:1, p <0.01). Conclusions: In Italy, GBS incidence was among the highest reported in Europe and higher than previously observed in Italian studies.",
keywords = "Axonal and demyelinating GBS, Guillain-Barr{\'e} syndrome, Incidence, Prospective study, Trend",
author = "Benedetti, {Maria Donata} and Maura Pugliatti and Roberto Dalessandro and Ettore Beghi and Adriano Chi{\`o} and Giancarlo Logroscino and Graziella Filippini and Francesca Galeotti and Marco Massari and Carmela Santuccio and Roberto Raschetti",
year = "2015",
month = "10",
day = "12",
doi = "10.1159/000438752",
language = "English",
volume = "45",
pages = "90--99",
journal = "Neuroepidemiology",
issn = "0251-5350",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study

AU - Benedetti, Maria Donata

AU - Pugliatti, Maura

AU - Dalessandro, Roberto

AU - Beghi, Ettore

AU - Chiò, Adriano

AU - Logroscino, Giancarlo

AU - Filippini, Graziella

AU - Galeotti, Francesca

AU - Massari, Marco

AU - Santuccio, Carmela

AU - Raschetti, Roberto

PY - 2015/10/12

Y1 - 2015/10/12

N2 - To assess Guillain-Barre syndrome (GBS) incidence we relied on the Italian Network for the study of GBS (ITANG) established in 2010 in 7 Italian regions to analyse the association between influenza vaccination and GBS. Methods: All individuals aged ≥18 years, presenting with clinical manifestations that suggested GBS according to the universally accepted Asbury's diagnostic criteria (1990) were prospectively notified to a centralised database by ITANG neurologists over the period October 1, 2010-September 30, 2011. Through a telephone survey, 9 trained interviewers followed up the cases to diagnosis and then for 1 year since hospital discharge. Validation of case reporting was performed with the support of administrative data in 5 regions. Results: We found 365 cases fulfilling the definition for GBS or one of its variants over 19,846,068 population ≥18 years of age, yielding an annual incidence rate of 1.84 per 100,000 (95% CI 1.65-2.03), 2.30 (95% CI 1.99-2.60) in men and 1.41 (95% CI 1.18-1.64) in women. A highly significant peak of incidence was observed in February 2011 as compared to reference month (September 2011, rate ratio 3.3:1, p <0.01). Conclusions: In Italy, GBS incidence was among the highest reported in Europe and higher than previously observed in Italian studies.

AB - To assess Guillain-Barre syndrome (GBS) incidence we relied on the Italian Network for the study of GBS (ITANG) established in 2010 in 7 Italian regions to analyse the association between influenza vaccination and GBS. Methods: All individuals aged ≥18 years, presenting with clinical manifestations that suggested GBS according to the universally accepted Asbury's diagnostic criteria (1990) were prospectively notified to a centralised database by ITANG neurologists over the period October 1, 2010-September 30, 2011. Through a telephone survey, 9 trained interviewers followed up the cases to diagnosis and then for 1 year since hospital discharge. Validation of case reporting was performed with the support of administrative data in 5 regions. Results: We found 365 cases fulfilling the definition for GBS or one of its variants over 19,846,068 population ≥18 years of age, yielding an annual incidence rate of 1.84 per 100,000 (95% CI 1.65-2.03), 2.30 (95% CI 1.99-2.60) in men and 1.41 (95% CI 1.18-1.64) in women. A highly significant peak of incidence was observed in February 2011 as compared to reference month (September 2011, rate ratio 3.3:1, p <0.01). Conclusions: In Italy, GBS incidence was among the highest reported in Europe and higher than previously observed in Italian studies.

KW - Axonal and demyelinating GBS

KW - Guillain-Barré syndrome

KW - Incidence

KW - Prospective study

KW - Trend

UR - http://www.scopus.com/inward/record.url?scp=84940768230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940768230&partnerID=8YFLogxK

U2 - 10.1159/000438752

DO - 10.1159/000438752

M3 - Article

VL - 45

SP - 90

EP - 99

JO - Neuroepidemiology

JF - Neuroepidemiology

SN - 0251-5350

IS - 2

ER -